This is from Clintrial.gov:
Overall Survival (OS) [ Time Frame: From date of randomization until the date of death from any cause, or until 12 months following last patient randomization (approximately 2 years), whichever comes first. ]
Last patient in for the paxalisib arm was around April/May 2022. Which means around now they can close the data collection for the paxalisib arm, clean the data and analyse it. Unless that’s done on a rolling basis (maybe not possible due to blinding of data?) they will need about 3 months to have analyses ready.
Very late Q3 or Q4 is still the best bet for a GBM AGILE read-out for paxalisib.
- Forums
- ASX - By Stock
- Ann: Kazia presents new data at AACR Annual Meeting
This is from Clintrial.gov:Overall Survival (OS) [ Time Frame:...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)